Partnering with CDMOs can help bridge the innovation gap.
Paul Nelles
Advertisement
Vice President, Vetter Development Service, Vetter Pharma-Fertigung GmbH & Co. KG
Articles by Paul Nelles
Biotechnology projects are complex and subject to many levels of risk during the early clinical phases. What are the secrets to winning at the drug development game?
Advertisement
Latest Updated Articles
Playing the Drug Development GameDecember 19th 2011
Strategic Outsourcing in Clinical DevelopmentDecember 16th 2013
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
3
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
4
Ionis Reports 2-Year Donidalorsen (Dawnzera) Data in HAE Prophylaxis
5